HUMA
Humacyte, Inc. · Healthcare
Director Brady W Dougan sold $5.7M of Humacyte, Inc.
Sold$5,724,139
$6.49Price
881,878Shares
−14%Stake
What HUMA did after the filing
- The stock from Thu, Aug 29 close, $6.15
- −6.8%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Oct 11 close.
Traded Tue, Aug 27. Filed Thu, Aug 29, 2:52 PM ET, during the session. Returns use the Aug 29 close and the Oct 11 close. Not investment advice.